These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837 [TBL] [Abstract][Full Text] [Related]
3. Melioidosis: antibiogram of cases in Singapore 1987-2007. Tan AL; Tan ML Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S101-2. PubMed ID: 19121668 [TBL] [Abstract][Full Text] [Related]
4. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Crowe A; McMahon N; Currie BJ; Baird RW Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662 [TBL] [Abstract][Full Text] [Related]
5. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials. Karunakaran R; Puthucheary SD Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore. Sivalingam SP; Sim SH; Aw LT; Ooi EE J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412 [No Abstract] [Full Text] [Related]
8. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. Nicodemo AC; Araujo MR; Ruiz AS; Gales AC J Antimicrob Chemother; 2004 Apr; 53(4):604-8. PubMed ID: 14973153 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients. Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514 [TBL] [Abstract][Full Text] [Related]
10. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Chierakul W; Anunnatsiri S; Short JM; Maharjan B; Mootsikapun P; Simpson AJ; Limmathurotsakul D; Cheng AC; Stepniewska K; Newton PN; Chaowagul W; White NJ; Peacock SJ; Day NP; Chetchotisakd P Clin Infect Dis; 2005 Oct; 41(8):1105-13. PubMed ID: 16163628 [TBL] [Abstract][Full Text] [Related]
11. Cases of melioidosis in a university teaching hospital in Malaysia. Raja NS J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106 [TBL] [Abstract][Full Text] [Related]
12. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Piliouras P; Ulett GC; Ashhurst-Smith C; Hirst RG; Norton RE Int J Antimicrob Agents; 2002 May; 19(5):427-9. PubMed ID: 12007851 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam. Nhung PH; Van VH; Anh NQ; Phuong DM J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods. Lau SK; Wong GK; Poon RW; Lee LC; Leung KW; Tse CW; Ho PL; Que TL; Woo PC; Yuen KY J Antimicrob Chemother; 2009 Apr; 63(4):704-8. PubMed ID: 19202149 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method. Maloney S; Engler C; Norton R J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203 [TBL] [Abstract][Full Text] [Related]
16. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand. Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020 [No Abstract] [Full Text] [Related]
17. Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of Lonsway DR; Elrod MG; Kendrick N; Tiller R; Sullivan MM; Edwards JR; Blaney DD; Karlsson M Microb Drug Resist; 2020 Apr; 26(4):311-318. PubMed ID: 31596673 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh. Dutta S; Haq S; Hasan MR; Haq JA BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591 [TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin. Harris P; Engler C; Norton R Int J Antimicrob Agents; 2011 Jun; 37(6):547-9. PubMed ID: 21481571 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia. Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]